Literature DB >> 26082512

Editorial Commentary: Another Call to Cure Hepatitis B.

Ashwin Balagopal1, Chloe L Thio1.   

Abstract

Entities:  

Keywords:  HBV reactivation; HBV-HCV coinfection; IP-10; ISG; interferon

Mesh：

Substances：

Year:  2015        PMID： 26082512      PMCID： PMC4583579          DOI： 10.1093/cid/civ475

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  23 in total

1.  DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.

Authors:  C B Bigger; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Hepatitis C virus core and E2 protein expression in transgenic mice.

Authors:  C Pasquinelli; J M Shoenberger; J Chung; K M Chang; L G Guidotti; M Selby; K Berger; R Lesniewski; M Houghton; F V Chisari
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

3.  Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein.

Authors:  Shiow-Yi Chen; Chih-Fei Kao; Chun-Ming Chen; Chwen-Ming Shih; Ming-Jen Hsu; Chi-Hong Chao; Shao-Hung Wang; Li-Ru You; Yan-Hwa Wu Lee
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

4.  Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.

Authors:  Elisavet Serti; Xenia Chepa-Lotrea; Yun Ju Kim; Meghan Keane; Nancy Fryzek; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

5.  Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.

Authors:  Jennifer C Lin; François Habersetzer; Maribel Rodriguez-Torres; Nezam Afdhal; Eric J Lawitz; Matthew S Paulson; Yanni Zhu; Gangadharan Mani Subramanian; John G McHutchison; Mark Sulkowski; David L Wyles; Robert T Schooley
Journal:  J Infect Dis       Date:  2014-06-06       Impact factor: 5.226

6.  Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.

Authors:  Harel Dahari; Marian Major; Xinan Zhang; Kathleen Mihalik; Charles M Rice; Alan S Perelson; Stephen M Feinstone; Avidan U Neumann
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

7.  Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients.

Authors:  S B Wiegand; J Jaroszewicz; A Potthoff; C Höner Zu Siederdissen; B Maasoumy; K Deterding; M P Manns; H Wedemeyer; M Cornberg
Journal:  Clin Microbiol Infect       Date:  2015-04-13       Impact factor: 8.067

Review 8.  Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?

Authors:  Adrian M Di Bisceglie; Anna S Lok; Paul Martin; Norah Terrault; Robert P Perrillo; Jay H Hoofnagle
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

9.  Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.

Authors:  Elena Rodríguez-Iñigo; Luisa Mariscal; Javier Bartolomé; Inmaculada Castillo; Cristina Navacerrada; Nuria Ortiz-Movilla; Margarita Pardo; Vicente Carreño
Journal:  J Med Virol       Date:  2003-08       Impact factor: 2.327

10.  Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.

Authors:  Jeffrey M Collins; Kara Loren Raphael; Charles Terry; Emily J Cartwright; Anjana Pillai; Frank A Anania; Monica M Farley
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079
View more
  3 in total

Review 1.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

2.  When viruses collide: hepatitis B virus reactivation after hepatitis C treatment.

Authors:  Ashwin Balagopal; Chloe L Thio
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

Authors:  Mark S Sulkowski; Wan-Long Chuang; Jia-Horng Kao; Jenny C Yang; Bing Gao; Diana M Brainard; Kwang-Hyub Han; Edward Gane
Journal:  Clin Infect Dis       Date:  2016-08-02       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.